cirrhosis also known liver cirrhosis hepatic cirrhosis endstage liver disease impaired liver function caused formation scar tissue known fibrosis due damage caused liver damage liver leads repair liver tissue subsequent formation scar tissue time scar tissue replace normal functioning tissue leading impaired liver function disease typically develops slowly months early symptoms may include tiredness weakness loss appetite unexplained weight loss nausea vomiting discomfort right upper quadrant disease worsens symptoms may include itchiness swelling lower legs fluid buildup abdomen jaundice bruising easily development spiderlike blood vessels fluid buildup abdomen may develop spontaneous serious complications include hepatic encephalopathy bleeding dilated veins esophagus stomach intestines liver cirrhosis commonly caused alcoholic liver disease nonalcoholic steatohepatitis nash progressive form nonalcoholic fatty liver heroin chronic hepatitis b chronic hepatitis heavy drinking number years cause alcoholic liver liver damage also attributed heroin usage extended period time nash number causes including obesity high blood pressure abnormal levels cholesterol type diabetes metabolic less common causes cirrhosis include autoimmune hepatitis primary biliary cholangitis primary sclerosing cholangitis disrupts bile duct function genetic disorders wilsons disease hereditary hemochromatosis chronic heart failure liver diagnosis based blood tests medical imaging liver hepatitis b vaccine prevent hepatitis b development cirrhosis vaccination hepatitis c specific treatment cirrhosis known many underlying causes may treated number medications may slow prevent worsening hepatitis b c may treatable antiviral avoiding alcohol recommended autoimmune hepatitis may treated steroid ursodiol may useful disease due blockage bile medications may useful complications abdominal leg swelling hepatic encephalopathy dilated esophageal cirrhosis leads liver failure liver transplant may cirrhosis affected million people resulted million deaths deaths alcohol caused hepatitis c caused hepatitis b caused united states men die cirrhosis first known description condition hippocrates fifth century term cirrhosis derived greek word kirrhos describes yellowish color diseased cirrhosis take quite long time develop symptoms may slow early symptoms include tiredness weakness loss appetite weight loss people may also feel discomfort right upper abdomen around cirrhosis progresses symptoms include neurological consist cognitive impairments confusion memory loss sleep disorders personality worsening cirrhosis cause buildup fluid different parts body legs edema abdomen signs advancing disease include itchy skin bruising easily dark urine yellowing features direct consequence liver cells functioning liver cirrhosis makes hard blood flow portal venous resistance creates backup blood increases results portal hypertension effects portal hypertension include signs may present include changes nails muehrckes lines terrys nails nail additional changes may seen hands dupuytrens contracture well skinbones hypertrophic disease progresses complications may develop people may first signs disease cirrhosis many possible causes one cause may present history taking importance trying determine likely globally cirrhosis attributable either hepatitis b hepatitis c alcohol use disorder another major cause accounting liver plays vital role synthesis proteins example albumin clotting factors complement detoxification storage example vitamin glycogen addition participates metabolism lipids carbohydratescitation needed cirrhosis often preceded hepatitis fatty liver steatosis independent cause cause removed stage changes fully reversiblecitation needed pathological hallmark cirrhosis development scar tissue replaces normal tissue scar tissue blocks portal flow blood organ raising blood pressure disturbing normal function research shown pivotal role stellate cell normally stores vitamin development cirrhosis damage liver tissue inflammation leads activation stellate cells increases fibrosis production myofibroblasts obstructs hepatic blood addition stellate cells secrete tgf beta leads fibrotic response proliferation connective tissue implicated process activating hepatic stellate cells hscs magnitude fibrosis proportion increase tgf β levels associated tgf β pathway enhances contractile properties hscs leading furthermore hscs secrete naturally occurring inhibitors matrix metalloproteinases mmps prevent mmps breaking fibrotic material extracellular cascade processes continues fibrous tissue bands septa separate hepatocyte nodules eventually replace entire liver architecture leading decreased blood flow throughout spleen becomes congested enlarged resulting retention platelets needed normal blood clotting portal hypertension responsible severe complications cirrhosiscitation needed diagnosis cirrhosis individual based multiple cirrhosis may suspected laboratory findings physical exam persons medical history imaging generally obtained evaluate liver biopsy confirm diagnosis however generally ultrasound routinely used evaluation may show small shrunken liver advanced disease ultrasound increased echogenicity irregular appearing suggestive findings enlarged caudate lobe widening fissures enlargement enlarged spleen normally measures less cm adults may suggest underlying portal ultrasound may also screen hepatocellular carcinoma portal done assessing flow hepatic increased portal vein pulsatility may seen however may sign elevated right atrial portal vein pulsatility usually measured pulsatility indices number certain values indicates cirrhosis see table scans include ct abdomen ct scan noninvasive may helpful compared ultrasound ct scans tend expensive mri provides excellent evaluation however high cirrhosis also diagnosable variety new elastography liver becomes cirrhotic generally become stiffer determining stiffness imaging determine location severity disease techniques include transient elastography acoustic radiation force impulse imaging supersonic shear imaging magnetic resonance transient elastography magnetic resonance elastography help identify stage compared biopsy elastography sample much larger area shows reasonable correlation severity modalities introduced incorporated ultrasonagraphy systems include shear wave elastography point shear wave elastography uses acoustic radiation force impulse rarely diseases bile ducts primary sclerosing cholangitis causes imaging bile ducts ercp mrcp mri biliary tract pancreas may aid best predictors cirrhosis ascites platelet count spider angiomata bonacini cirrhosis discriminant score greater sum scores platelet count altast ratio inr per findings typical cirrhosis fibrotest biomarker fibrosis may used instead laboratory studies performed newly diagnosed cirrhosis may include markers inflammation immune cell activation typically elevated cirrhotic patients especially decompensated disease stage recent study microbial biomarkers gut could potentially used discriminate patients liver cirrhosis healthy individuals gold standard diagnosis cirrhosis liver biopsy usually carried fineneedle approach skin percutaneous internal jugular vein endoscopic ultrasoundguided liver biopsy eus using percutaneous transjugular route become good alternative eus target liver areas widely deliver bilobar biopsy necessary clinical laboratory radiologic data suggest cirrhosis furthermore small significant risk complications associated liver biopsy cirrhosis predisposes complications caused liver biopsy obtained pathologist study sample cirrhosis defined features microscopy presence regenerating nodules hepatocytes presence fibrosis deposition connective tissue nodules pattern fibrosis seen depend underlying insult led cirrhosis fibrosis also proliferate even underlying process caused resolved ceased fibrosis cirrhosis lead destruction normal tissues liver including sinusoids space disse vascular structures leads altered resistance blood flow liver portal fibrosis mild zone steatosis collagen fibres arrow confined portal tracts p van giesons histopathology steatohepatitis mild fibrosis form fibrous expansion van giesons histopathology steatohepatitis moderate fibrosis thin fibrous bridges van giesons histopathology steatohepatitis established cirrhosis thick bands fibrosis van giesons trichrome stain showing cirrhosis nodular texture surrounded fibrosis wherein collagen stained blue cirrhosis caused many different entities injure liver different ways causespecific abnormalities may seen example chronic hepatitis b infiltration liver parenchyma congestive hepatopathy erythrocytes greater amount fibrosis tissue surrounding hepatic primary biliary cholangitis fibrosis around bile duct presence granulomas pooling lastly alcoholic cirrhosis infiltration liver macroscopically liver initially enlarged progression disease becomes smaller surface irregular consistency firm associated steatosis color yellow depending size nodules three macroscopic types micronodular macronodular mixed cirrhosis micronodular form laennecs cirrhosis portal cirrhosis regenerating nodules mm macronodular cirrhosis postnecrotic cirrhosis nodules larger mm mixed cirrhosis consists nodules different micronodular cirrhosis diffuse areas pallor pale macronodules cirrhosis cirrhosis leading hepatocellular carcinoma severity cirrhosis commonly classified score also known system devised child turcotte modified pugh first established determine would benefit elective surgery portal scoring system uses multiple lab values including bilirubin albumin presence ascites severity encephalopathy also included classification system includes class b class favorable prognosis class c high risk death childpugh score validated predictor mortality major example child class patients mortality rate child class b patients mortality rate child class c patients mortality rate abdominal elective surgery usually reserved child class patients increased risk child class b individuals may require medical optimization overall recommended child class c patients undergo elective past childpugh classification used determine people candidates liver childpugh class b usually indication evaluation however many issues applying score liver transplant thus meld score created model endstage liver disease meld score later developed approved approved united network organ sharing unos way determine allocation liver transplants awaiting people united also used validated survival predictor cirrhosis alcoholic hepatitis acute liver failure acute variables included bilirubin inr creatinine dialysis sodium added variables score often referred meldplus risk score assess severity chronic liver disease developed result collaboration massachusetts general hospital nine variables identified effective predictors mortality discharge cirrhosisrelated hospital variables include model endstage liver disease melds components well sodium albumin total cholesterol white blood cell count age length hepatic venous pressure gradient difference venous pressure incoming outgoing blood liver also determines severity cirrhosis although hard measure value mm means greatly increased risk medical source key prevention strategies cirrhosis populationwide interventions reduce alcohol intake pricing strategies public health campaigns personal counseling programs reduce transmission viral hepatitis screening relatives people hereditary liver little known factors affecting cirrhosis risk progression however many studies provided increasing evidence protective effects coffee consumption progression liver disease effects noticeable liver disease associated alcohol use disorder coffee antioxidant antifibrotic effects caffeine may important component polyphenols may important drinking two cups coffee day associated improvements liver enzymes alt ast ggt even liver disease coffee consumption lower fibrosis generally liver damage cirrhosis reversed treatment stop delay progression reduce complications healthy diet encouraged cirrhosis may energyconsuming process recommended diet consists highprotein highfiber diet plus supplementation branchedchain amino close followup often necessary antibiotics prescribed infections various medications help itching laxatives lactulose decrease risk constipation carvedilol increases survival benefit people cirrhosis portal alcoholic cirrhosis caused alcohol use disorder treated abstaining alcohol treatment hepatitisrelated cirrhosis involves medications used treat different types hepatitis interferon viral hepatitis corticosteroids autoimmune hepatitiscitation needed cirrhosis caused wilsons disease treated removing copper builds carried using chelation therapy penicillamine cause iron overload iron removed using chelation agent deferoxamine bloodlettingcitation needed recent studies studying drugs prevent cirrhosis caused nonalcoholic fatty liver disease nafld nash drug called semaglutide shown provide greater nash resolution versus placebo improvement fibrosis combination cilofexorfirsocostat studied people bridging fibrosis cirrhosis observed led improvements nash activity potential antifibrotic lanifibranor also shown prevent worsening regardless underlying cause cirrhosis consumption alcohol potentially damaging substances discouraged evidence supports avoidance dose reduction paracetamol people compensated cirrhosis thus considered safe analgesic said people risk exposed hepatitis hepatitis b consider vaccines diseasescitation needed treating cause cirrhosis prevents damage example giving oral antivirals entecavir tenofovir cirrhosis due hepatitis b prevents progression cirrhosis similarly control weight diabetes prevents deterioration cirrhosis due nonalcoholic fatty liver people cirrhosis liver damage often advised avoid drugs could harm include several drugs antidepressants certain antibiotics nsaids like agents hepatotoxic metabolized liver medication harms liver still recommended doctor dosage adjusted aim minimal stress livercitation needed according systematic review based studies implemented weeklong exercise programs currently insufficient scientific evidence regarding either beneficial harmful effects physical exercise people cirrhosis allcause mortality morbidity including serious nonserious adverse events healthrelated quality life exercise capacity anthropomorphic conclusions based low low quality research imposes need develop research higher quality especially evaluate effects clinical outcomescitation needed complications controlled liver ceases functioning liver transplantation necessary survival liver transplantation improving fiveyear survival rate around survival rate depends largely severity disease medical risk factors united states meld score used prioritize patients transplantation necessitates use immune suppressants ciclosporin tacrolimus manifestations decompensation cirrhosis include gastrointestinal bleeding hepatic encephalopathy jaundice ascites patients previously stable cirrhosis decompensation may occur due various causes constipation infection source increased alcohol intake medication bleeding esophageal varices dehydration may take form complications cirrhosis listed people decompensated cirrhosis generally require admission hospital close monitoring fluid balance mental status emphasis adequate nutrition medical treatment often diuretics antibiotics laxatives enemas thiamine occasionally steroids acetylcysteine administration saline avoided would add already high total body sodium content typically occurs cirrhosis life expectancy without liver transplant low three years palliative care specialized medical care focuses providing patients relief symptoms pain stress serious illness cirrhosis goal palliative care improve quality life patient patients family appropriate stage type especially later stages people cirrhosis experience significant symptoms abdominal swelling itching leg edema chronic abdominal pain would amenable treatment palliative disease curable without transplant palliative care also help discussions regarding persons wishes concerning health care power attorney resuscitate decisions life support potentially despite proven benefit people cirrhosis rarely referred palliative cirrhosis known cause immune dysfunction numerous ways impedes immune system working normallycitation needed cirrhosis increase risk bleeding liver produces various proteins coagulation cascade coagulation factors ii vii ix x v vi damaged liver impaired production ultimately increase bleeding clotting factors diminished clotting function estimated lab values mainly platelet count prothrombin time pt international normalized ratio inr american gastroenterological association aga provided recommendations regards coagulopathy management cirrhotic patients certain salt restriction often necessary cirrhosis leads accumulation salt sodium retention diuretics may necessary suppress ascites diuretic options inpatient treatment include aldosterone antagonists spironolactone loop diuretics aldosterone antagonists preferred people take oral medications need urgent volume reduction loop diuretics added additional salt restriction use diuretics ineffective paracentesis may preferred procedure requires insertion plastic tube peritoneal cavity human serum albumin solution usually given prevent complications rapid volume reduction addition rapid diuretics liters paracentesis successful comparison diuretic portal hypertension nonselective beta blockers propranolol nadolol commonly used lower blood pressure portal system severe complications portal hypertension transjugular intrahepatic portosystemic shunting tips occasionally indicated relieve pressure portal vein shunting worsen hepatic encephalopathy reserved patients low risk encephalopathy tips generally regarded bridge liver palliative measurecitation needed balloonoccluded retrograde transvenous obliteration used treat gastric variceal gastroscopy endoscopic examination esophagus stomach duodenum performed cases established cirrhosis esophageal varices found prophylactic local therapy may applied sclerotherapy banding beta blockers may hepatic encephalopathy potential complication may lead functional neurological impairment ranging mild confusion goal treatment reducing achieved administering lactulose lactitol increase hydration nutritional support also protein uptake underlying cause may also need identified treated causes include alcohol use excess protein gastrointestinal bleeding infection constipation drugs like benzodiazepines diuretics narcotics also precipitate hepatic low protein diet recommended gastrointestinal rifaximin administered mental state improve antibiotic treatment may need continued least three grading severity hepatic encephalopathy determined mental status hepatorenal syndrome serious complication endstage cirrhosis kidney damage also people ascites due cirrhosis risk spontaneous bacterial peritonitis portal hypertensive gastropathy refers changes mucosa stomach people portal hypertension associated cirrhosis cirrhosis cause immune system dysfunction leading infection signs symptoms infection may nonspecific difficult recognize example worsening encephalopathy moreover infections cirrhosis major triggers complications ascites variceal bleeding hepatic encephalopathy organ failures hepatocellular carcinoma common primary liver cancer common cause death people screening using mri scan detect cancer often carried early signs shown improve year approximately one million deaths due complications cirrhosis making cirrhosis common cause death cirrhosis chronic liver disease tenth leading cause death men twelfth women united states killing people cause cirrhosis vary alcohol nonalcoholic fatty liver disease main causes western industrialized countries whereas viral hepatitis predominant cause low middleincome cirrhosis common men cost cirrhosis terms human suffering hospital costs lost productivity high globally agestandardized disabilityadjusted life year daly rates decreased values going years per people years per males daly rates decreased years per population years per population females daly rates decreased years per population years per population however globally total number dalys increased million reaching value million word cirrhosis neologism derived greek κίρρωσις kirrhos κιρρός meaning yellowish tawny orangeyellow colour diseased liver suffix osis ie condition medical clinical entity known rené laennec gave name httpsenwikipediaorgwikicirrhosis